1. 1) Esposito E, Cuzzocrea S. New therapeutic strategy for Parkinson’s and Alzheimer’s disease. Curr. Med. Chem., 17, 2764–2774 (2010).
2. 2) Giacobini E. Cholinergic function and Alzheimer’s disease. Int. J. Geriatr. Psychiatry, 18 (Suppl. 1), S1–S5 (2003).
3. 3) Oda Y. Choline acetyltransferase: The structure, distribution and pathologic changes in the central nervous system. Pathol. Int., 49, 921–937 (1999).
4. 4) Roghani A, Carroll PT. Analysis of uptake and release of newly synthesized acetylcholine in PC12 cells overexpressing the rat vesicular acetylcholine transporter (VAChT). Brain Res. Mol. Brain Res., 100, 21–30 (2002).
5. 5) Chen KH, Reese EA, Kim H-W, Rapoport SI, Rao JS. Disturbed neurotransmitter transporter expression in Alzheimer disease brain. J. Alzheimers Dis., 26, 755–766 (2011).